News

CoapTech, LLC, and University of Maryland, Baltimore Set Stage to Commercialize Novel Procedure for Placing Feeding Tubes

umventures-logo-trans

– Start-up Company Developing Safer, Less Expensive Gastrostomy Method – CoapTech Receives Maryland Innovative Initiative Award to Further Advance the Technology BALTIMORE, Nov. 29, 2016 /PRNewswire/ — University of Maryland (UM) Ventures and CoapTech, LLC, announced today that the University of Maryland, Baltimore (UMB) has granted CoapTech exclusive licensing rights for the commercial development of […]

Comments Off on CoapTech, LLC, and University of Maryland, Baltimore Set Stage to Commercialize Novel Procedure for Placing Feeding Tubes Continue Reading →

GlycoMimetics Joins New Sickle Cell Disease Coalition, Issues Call to Action to Improve Treatment and Care

logo-glyco

GlycoMimetics joins leading patient advocacy groups, researchers, clinicians, policymakers, industry, and foundations in a collective effort to improve sickle cell disease (SCD) care, early diagnosis, treatment, and research both in the United States and globally. The newly formed Sickle Cell Disease Coalition’s first order of business is an international call to action to change the […]

Comments Off on GlycoMimetics Joins New Sickle Cell Disease Coalition, Issues Call to Action to Improve Treatment and Care Continue Reading →

Maryland Economic Development Corporation Partners with BioHealth Innovation, Inc. to Manage Germantown Innovation Center

bhilogo

ROCKVILLE, Md., Oct. 24, 2016 /PRNewswire/ — BioHealth Innovation, Inc. (BHI) announced today that the Maryland Economic Development Corporation (MEDCO), who is the agent for Montgomery County, has selected BHI to manage the Germantown Innovation Center (GIC) located within the Pinkney Innovation Complex for Science and Technology at Montgomery College (PIC MC). The Germantown Innovation […]

Comments Off on Maryland Economic Development Corporation Partners with BioHealth Innovation, Inc. to Manage Germantown Innovation Center Continue Reading →

WBJ: Gaithersburg Rare Disease Startup Vtesse Inc. Nabs $17M in Additional Series A Funding

Vtesse, Inc. logo (PRNewsFoto/Vtesse, Inc.)

Gaithersburg biotech startup Vtesse Inc. — a company with a goal to commercialize National Institutes of Health rare disease drug candidates — secured $17 million in additional Series A funding. Read more via the Washington Business Journal

Comments Off on WBJ: Gaithersburg Rare Disease Startup Vtesse Inc. Nabs $17M in Additional Series A Funding Continue Reading →

VAYA Pharma, a Fast Growing Pioneer in Using Lipids to Treat Disease, Settles in UM BioPark

UMBioPark-Twitter-Profile-Image

Three common disorders that are on the rise worldwide—attention deficit hyperactivity disorder (ADHD), memory loss, and cardiovascular disease—may be more manageable thanks to a growing area of research and development in “medical foods.” And VAYA Pharma, one of the newest BioPark tenants, is developing medical foods that may hold the key to better management of […]

Comments Off on VAYA Pharma, a Fast Growing Pioneer in Using Lipids to Treat Disease, Settles in UM BioPark Continue Reading →

Vtesse Advances Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease with Dose Selection for Evaluation in Second and Final Portion of Trial and Expansion into Europe

Vtesse, Inc. logo (PRNewsFoto/Vtesse, Inc.)

Ten clinical sites now enrolling patients in the United States, the United Kingdom, Spain, France and Germany Vtesse, Inc. announced that the dose-finding portion of the company’s global, pivotal Phase 2b/3 clinical trial for its lead investigational product, VTS-270, for treatment of Niemann-Pick Type C1 Disease (NPC) is now complete, and a dose level for further […]

Comments Off on Vtesse Advances Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease with Dose Selection for Evaluation in Second and Final Portion of Trial and Expansion into Europe Continue Reading →

Relevant Health Holds Demo Day for Its Inaugural Cohort of Health Tech Startups

Relevant

At its first Demo Day on March 23, Relevant Health, a health technology startup accelerator in the Washington, DC metro area, hosted a group of more than 150 investors, industry leaders and top technology company representatives to experience first-hand the progress of the accelerator’s seven health tech startups. Coming from Bethesda, Rockville, Washington, DC, Baltimore, […]

Comments Off on Relevant Health Holds Demo Day for Its Inaugural Cohort of Health Tech Startups Continue Reading →